Agilon Health (AGL)
US Market

Agilon Health (AGL) Income Statement


Agilon Health Income Statement

Last quarter (Q4 2023), Agilon Health's total revenue was $815.50M, an increase of 18.23% from the same quarter last year. In Q4, Agilon Health's net income was $-230.43M. See Agilon Health’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 4.31B$ 4.32B$ 2.71B$ 1.83B$ 1.22B$ 794.41M
Cost of Revenue
$ 3.19B$ 4.25B--$ 1.12B$ 765.90M
Gross Profit
$ 1.13B$ 69.67M$ 2.71B$ 1.83B$ 94.15M$ 28.51M
Operating Expense
$ 301.80M$ 301.80M$ 2.83B$ 579.85M$ 150.82M$ 135.09M
Operating Income
$ 740.69M$ -232.13M$ -120.43M$ 1.25B$ -56.67M$ -106.57M
Net Non Operating Interest Income Expense
$ 2.81M$ -6.66M$ -4.53M$ -10.65M$ -8.13M$ -9.07M
Other Income Expense
$ -34.86M$ -44.33M$ 2.38B$ 1.65B$ 2.46M$ 955.00K
Pretax Income
$ -194.46M$ -194.46M$ -105.69M$ -404.60M$ -62.34M$ -114.69M
Tax Provision
$ 791.00K$ 791.00K$ 1.64M$ 886.00K$ 865.00K$ -232.00K
Earnings From Equity Interest Net Of Tax
$ 16.49M$ 16.49M$ 10.72M$ -6.77M--
Net Income Common Stockholders
$ -262.72M$ -262.60M$ 285.70M$ -406.49M$ -60.05M$ -282.59M
Basic EPS
$ -0.65$ -0.64$ -0.26$ -1.09$ -0.16$ -0.74
Diluted EPS
$ -0.67$ -0.64$ -0.26$ -1.09$ -0.16$ -0.74
Basic Average Shares
$ 1.64B$ 408.92M$ 408.15M$ 372.93M$ 384.02M$ 384.02M
Diluted Average Shares
$ 1.64B$ 408.92M$ 408.15M$ 372.93M$ 384.02M$ 384.02M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
$ 1.54B$ 4.55B$ 2.83B$ 579.85M$ 1.28B$ 900.99M
Net Income From Continuing And Discontinued Operation
$ -262.60M$ -262.60M$ -106.55M$ -406.49M$ -60.05M$ -282.59M
Normalized Income
$ -36.34M-$ -75.06M-$ -63.21M$ -114.30M
Interest Expense
----$ 8.13M$ 9.07M
$ -36.49M$ -187.80M$ -104.84M$ -393.95M$ -54.21M$ -105.62M
$ 1.83M$ -167.64M$ -91.06M$ -379.41M$ -40.11M$ -64.21M
Currency in USD

Agilon Health Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis